ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "genomics"

  • Abstract Number: 0766 • ACR Convergence 2024

    Neutrophil Transcriptomics in VEXAS Syndrome

    Chloe Palmer1, Gustaf Wigerblad1, Tom Hill2, Bhavisha Patel3, Emma Groarke4, Neal Young4, Stefania Dell'Orso5 and Peter Grayson6, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 2National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, 3National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Beltsville, MD, 4National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, 5National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, Bethesda, MD, 6National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Chevy Chase, MD

    Background/Purpose: Vacuoles, E1 ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is caused by somatic mutations of the ubiquitin-like modifier activating enzyme 1 (UBA1) gene and…
  • Abstract Number: 0960 • ACR Convergence 2024

    The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA Sequencing

    Matthew Dapas1, Margarette Clevenger1, Hadijat Makinde2, Tyler Therron1, Dustin Carlson1, Mary Carns3, Kathleen Aren3, Carrie Richardson2, Cenfu Wei2, Lutfiyya Muhammad4, John Pandolfino1, Harris Perlman2, Deborah Winter5 and Marie-Pier Tetreault1, 1Northwestern University, Chicago, 2Northwestern University, Chicago, IL, 3Northwestern University Division of Rheumatology, Chicago, IL, 4Northwestern Feinberg School of Medicine, Chicago, IL, 5Northwestern University, Skokie, IL

    Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by vasculopathy and progressive fibrosis of the skin and internal organs. Individuals with SSc often…
  • Abstract Number: 2036 • ACR Convergence 2024

    CCN6 Gene Mutation Induces Mitochondrial Dysfunction: The Cause of Progressive Pseudo-rheumatoid Dysplasia

    Yanhong Li1, Xiufeng Bai2 and Yi Liu3, 1West China School of Medicine and West China Hospital, Sichuan University, Cheng Du, Sichuan, China, 2West China Hospital, Sichuan University, Chengdu, Sichuan, China (People's Republic), 3West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Background/Purpose: Progressive pseudo-rheumatoid dysplasia (PPRD) is a rare autosomal recessive disorder characterized by non-inflammatory joint issues that primarily affect the articular cartilage. This leads to…
  • Abstract Number: 0869 • ACR Convergence 2024

    Deciphering Pathogenic Phenotypes by Multi-modal Deep Single-cell Blood Immunophenotyping in Individuals At-risk for Rheumatoid Arthritis

    Jun Inamo1, Joshua Keegan2, Alec Griffith2, Tusharkanti Ghosh1, Alice Horisberger2, Kaitlyn Howard2, John Pulford2, Ekaterina Murzin2, Brandon Hancock2, Thomas Eisenhaure3, Salina Dominguez4, Miranda Gurra5, Siddarth Gurajala3, Anna Helena Jonsson1, Jennifer Seifert6, Marie Feser7, Jill Norris8, Ye Cao2, William Apruzzese9, S. Louis Bridges10, Vivian Bykerk11, Susan Goodman12, Laura Donlin11, Gary S. Firestein13, Joan Bathon14, Laura B. Hughes15, Darren Tabechian16, Andrew Filer17, Costantino Pitzalis18, Jennifer Anolik19, Larry Moreland20, Nir Hacohen21, Joel Guthridge22, Judith James22, Carla Cuda5, Harris Perlman5, Michael B. Brenner2, Soumya Raychaudhuri23, Jeffrey Sparks24, Michael Holers7, Kevin Deane25, James A. Lederer26, Deepak Rao26 and Fan Zhang27, and the Accelerating Medicines Partnership RA/SLE Network, 1University of Colorado School of Medicine, Aurora, CO, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Broad Institute of MIT and Harvard, Cambridge, 4Northwestern University, Chicago, 5Northwestern University, Chicago, IL, 6University of Colorado and Oklahoma Medical Research Foundation, Aurora, CO, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 8Colorado School of Public Health, Denver, CO, 9Accelerating Medicines Partnership® Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Network, Boston, MA, 10Division of Rheumatology, Weill Cornell Medical College, New York, NY, 11Hospital For Special Surgery, New York, NY, 12Hospital for Special Surgery, New York 10025, NY, 13University of California, San Diego, La Jolla, 14Columbia University, New York, NY, 15University of Alabama at Birmingham Medicine, Birmingham, AL, 16University of Rochester Medical Center, Rochester, 17Rheumatology Research Group, Institute for Inflammation and Ageing, NIHR Birmingham Biomedical Research Center and Clinical Research Facility, University of Birmingham, Birmingham, United Kingdom, 18QMUL, Bromley Kent, United Kingdom, 19University of Rochester Medical Center, Rochester, NY, 20University of Colorado, Denver, CO, 21Broad Institute of MIT and Harvard, Boston, MA, 22Oklahoma Medical Research Foundation, Oklahoma City, OK, 23Brigham and Women's Hospital, Boston, MA, 24Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 25University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 26Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 27University of Colorado, Aurora, CO

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease with currently no effective prevention strategies. Single-cell technologies have been recently used to investigate established RA…
  • Abstract Number: 0962 • ACR Convergence 2024

    Characterizing the Contribution of Myeloid Cells to Limited and Diffuse Cutaneous Systemic Sclerosis

    Parker Jones1, Salina Dominguez2, Miranda Gurra3, Gaurav Gadhvi4, Tyler Therron2, Kathleen Aren5, Carla Cuda3, Monique Hinchcliff6, Harris Perlman3, Hadijat Makinde3 and Deborah Winter7, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University, Chicago, 3Northwestern University, Chicago, IL, 4University of Michigan, Ann Arbor, MI, 5Northwestern University Division of Rheumatology, Chicago, IL, 6Yale School of Medicine, Westport, CT, 7Northwestern University, Skokie, IL

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by multiorgan fibrosis. The two main subtypes are diffuse cutaneous SSc (dcSSc) and limited cutaneous SSc…
  • Abstract Number: 2267 • ACR Convergence 2024

    A Novel Blood-based Assay That Predicts Clinical Response to TNFα Inhibitors or Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis

    Maggie Louie1, Signe Fransen2, Katherine Dilger1, Kevin Lai1, Diana Abdueva3, David Chernoff4 and Jeffrey Curtis5, 1Aqtual Inc, Hayward, CA, 2Aqtual Inc., sf, CA, 3Aqtual Inc., Hayward, CA, 4SetPoint Medical, Sausalito, CA, 5University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Current rheumatoid arthritis (RA) treatments, including TNFa inhibitors (TNFi) and JAK inhibitors (JAKi), have transformed the management of RA by controlling symptoms and slowing…
  • Abstract Number: 0885 • ACR Convergence 2024

    Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions

    Dylan Kotliar1, Michelle Curtis1, Ryan Agnew1, Kathryn Weinand1, Aparna Nathan2, Yuriy Baglaenko1, Yu Zhao1, Pardis Sabeti3, Deepak Rao4 and Soumya Raychaudhuri1, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Broad Institute, Boston, MA, 4Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: T-cells play a key role in the pathogenesis of autoimmune disease and in protection against cancer and infection. Consequently, there is widespread interest in…
  • Abstract Number: 0965 • ACR Convergence 2024

    Scleroderma Associated Interstitial Lung Disease Is Characterized by Aberrant Lung Epithelial Remodeling

    Monica Yang1, Fred Deiter2, Emily Flynn2, Seoyeon Lee3, Jessica Neely1, John Greenland2, Marina Sirota2 and Paul Wolters2, 1UCSF, San Francisco, CA, 2UCSF, SF, 3Yale, New Haven

    Background/Purpose: Interstitial lung disease (ILD) is present in a majority of systemic sclerosis (SSc) patients and the leading cause of SSc-related mortality. A subset of…
  • Abstract Number: 2516 • ACR Convergence 2024

    Exome-Wide Rare Variant Association Study of Takayasu’s Arteritis

    Yiming Luo1, Zuoming deng2, Kaitlin Quinn3, Keith Sikora4, Daniel Kastner5, Krzysztof Kiryluk1, Amr Sawalha6, Peter Merkel7 and Peter Grayson8, and the Vasculitis Clinical Research Consortium, 1Columbia University Irving Medical Center, New York, NY, 2National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4National Institutes of Health, Bethesda, MD, 5National Human Genome Research Institute, Bethesda, MD, Bethesda, MD, 6University of Pittsburgh, Pittsburgh, 7University of Pennsylvania, Philadelphia, PA, 8National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Chevy Chase, MD

    Background/Purpose: Takayasu’s arteritis (TAK) is a rare inflammatory disease primarily involving the aorta and its major branches. Multiple genetic association studies on common variants in…
  • Abstract Number: 0887 • ACR Convergence 2024

    Identification of Rare Variants in Lupus-causing Genes in a Mixed Paediatric and Adult Connective Tissue Disease Cohort

    Anastasia-Vasiliki Madenidou1, Gillian Rice2, Terence Garner3, Sarah Dyball4, Alice Chieng5, Ben Parker6, Tracy Briggs7, Adam Stevens3 and Ian Bruce8, 1Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, 2Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, 3Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, United Kingdom, 4Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK, Manchester, United Kingdom, 5Department of Rheumatology, Royal Manchester Children's Hospital, Manchester, United Kingdom, Manchester, United Kingdom, 6Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 7Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, 8Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Connective tissue diseases (CTDs) are a family of heterogeneous autoimmune diseases with overlapping clinical features. Not all patients with features suggestive of a mendelian…
  • Abstract Number: 1354 • ACR Convergence 2024

    The Association of Genetic Variation in PTPN22 and Rheumatoid Arthritis Disease Activity

    Thomas Riley1, Austin Wheeler2, Bryant England2, grant Cannon3, Sauer brian4, Gary Kunkel5, Katherine Wysham6, Beth Wallace7, Rachel Elam8, Paul Monach9, Andreas Reimold10, Gail Kerr11, Isaac Smith12, John Richards13, Iris Lee14, Rui Xiao15, Scott Damrauer15, Michael George15, Ted Mikuls2 and Joshua Baker15, 1Hopsital of the University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3University of Utah and Salt Lake City VA, Salt Lake City, UT, 4Salt Lake City VA/University of Utah, Salt Lake City, UT, 5University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 6VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 7Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 8Augusta University, Evans, GA, 9VA Boston Healthcare System, Boston, MA, 10Dallas VA Medical Center, Dallas, TX, 11Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 12Duke University Hospital, Durham, NC, 13Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 14Washington University in St Louis, Saint Louis, MO, 15University of Pennsylvania, Philadelphia, PA

    Background/Purpose: PTPN22 R620W is a common genetic variation that is a known risk factor for the development of autoimmune disease, including rheumatoid arthritis (RA). This…
  • Abstract Number: 2629 • ACR Convergence 2024

    Deciphering Salivary Gland Inflammation in Sjögren’s Syndrome Reveals Shared and Autoantibody-Specific Immune Cell Heterogeneity

    Jun Inamo1, Masaru Takeshita2, Katsuya Suzuki2, Kazuyuki Tsunoda2, Satoshi Usuda2, Junko Kuramoto2, Tsutomu Takeuchi3 and Yuko Kaneko4, 1University of Colorado School of Medicine, Aurora, CO, 2Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan, 3Department of Internal Medicine, Keio University, Tokyo, Tokyo, Japan, 4Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JP, Shinjuku-ku, Tokyo, Japan

    Background/Purpose: Sjögren's syndrome (SS) is an autoimmune disease characterized by progressive immune cell-mediated destruction of the exocrine glands. SS patients have distinct clinical phenotypes based…
  • Abstract Number: 0888 • ACR Convergence 2024

    Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts

    Kevin Sheridan1, Emma Doris1, Maria Pimenta1, Jemma Falkov1, Matthew Fisher2, Munitta Muthana2, Denis Shields1, Richard Mains3, Betty Eipper3, Christopher Buckley4 and Anthony Wilson5, 1University College Dublin, Dublin, Ireland, 2University of Sheffield, Sheffield, United Kingdom, 3University of Connecticut, Connecticut, 4University of Oxford, Oxford, United Kingdom, 5UCD, Dublin, Dublin, Ireland

    Background/Purpose: The SNP rs26232 is associated with both risk and severity of rheumatoid arthritis (RA), with the C allele associated with the susceptibility to RA,…
  • Abstract Number: 1761 • ACR Convergence 2024

    Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry

    Sabrina George1, Hannah C Ainsworth2, Kaiyu Jiang3, Gilad Barshad4, Adam He4, Edward Rice4, Carl D Langerfeld2, Charles G Danko4 and James N Jarvis3, 1University at Buffalo Jacobs School of Medicine, Buffalo, NY, 2Wake Forest University, Winston-Salem, NC, 3University of Washington School of Medicine, Seattle, WA, 4Cornell University Baker School of Veterinary Medicine, Ithaca, NY

    Background/Purpose: - Numerous juvenile idiopathic arthritis (JIA) risk loci have been identified, overwhelmingly from cohorts of children of European ancestry (EA). The extent to which…
  • Abstract Number: 2634 • ACR Convergence 2024

    Transcriptomic Stratification Predicts Response to Rituximab, Abatacept or the Association of Hydroxychloroquine and Leflunomide in 3 Randomized Controlled Clinical Trials in Sjögren’s Disease

    Baptiste Chevet1, Valerie Devauchelle2, Elena Pontarini3, Valentin Baloche4, Michele Bombardieri5, Simon Bowman6, Michael Barnes7, Antoine Sreih8, Jinqi Liu8, Sheila Kelly9, Antonia Christodoulou8, Hussain Badani10, Philippe Moigeon11, Laurence LAIGLE12, Perrine Soret13, Christelle Le dantec14, Jacques-Olivier Pers15, Marta Alarcon-Riquelme16, Guillermo Barturen17, Xavier Mariette18, Joel Van Roon19, Raphaele Seror20, Gaetane Nocturne18, Divi Cornec21 and Nathan Foulquier14, and PRECSEADS Clinical Consortium and NECESSITY consortium, 1University Hospital of Brest, Brest, France, 2UBO, Brest, France, 3William Harvey Research Institute, London, United Kingdom, 4University Medical Center, Utrecht, Utrecht, Netherlands, 5Centre for Experimental Medicine and Rheumatology, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom, 6Department of Rheumatology, University Hospital Birmingham, Birmingham, United Kingdom, 7William Harvey Research institute, Centre for Translational Bioinformatics, London, United Kingdom, 8Bristol Myers Squibb, Princeton, NJ, 9Bristol Myers Squibb, Doylestown, PA, 10Bristol Myers Squibb, Lawrence Township, NJ, 11Servier Laboratories, France, Gif sur Yvette, France, 12Servier Laboratories, France, SURESNES, France, 13Servier, Paris-Saclay, Paris, Ile-de-France, France, 14LBAI. UMR 1227, University of Brest, Brest, France, 15University of Brest, Brest, France, 16Fundación Progreso y Salud, Andalusian Government, Granada, Spain, 17Center for Genomics and Oncological Research (GENYO), Andalusia, Spain, 18Service de Rhumatologie, Hôpital Bicêtre, AP-HP, Le Kremlin Bicetre, France, 19University Medical Center Utrecht, Utrecht, Netherlands, 20Service de Rhumatologie, Hôpital Bicêtre, AP-HP, le Kremlin Bicetre, Ile-de-France, France, 21Service de Rhumatologie, CHU de Brest, Brest, France

    Background/Purpose: Sjögren’s disease (SjD) is a clinically and biologically heterogeneous disease. To date, no phase-III trial showed efficacy in reducing the symptoms or systemic activity…
  • 1
  • 2
  • 3
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology